VEGF Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NB100-2381
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse, Rat, Bovine, Canine, Chicken, Equine, Guinea Pig
Cited:
Human, Mouse, Rat, Avian - Chicken
Applications
Validated:
Western Blot, ELISA
Cited:
Western Blot, ELISA
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
BSA Free
Concentration
1.0 mg/ml
Product Specifications
Immunogen
A synthetic peptide made to an internal region of the human VEGFA protein sequence (between residues 180-232).
Localization
Secreted
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for VEGF Antibody - BSA Free
Western Blot: VEGF AntibodyBSA Free [NB100-2381]
Western Blot: VEGF Antibody [NB100-2381] - Detection of VEGFA doublet in CSF-IR/VEGFA chimera transfected lysate using.Western Blot: VEGF Antibody - BSA Free [NB100-2381] -
HIF-1 alpha protein and HIF-1 alpha target genes are elevated in SCs following retrovirus administration. Expression of mRNA for VP16, HIF-1 alpha, and beta-actin in transfected SCs was confirmed by PCR in VP16 and VP16-HIF SCs (A). Protein expression of VP16, HIF-1 alpha, HIF-2 alpha, VEGF, enolase, and protein loading controls (GFP or beta-actin) in transfected SCs was assessed by western blotting (B). Protein expression was normalized to the loading control. Relative intensity of VP16 expression is shown in C, and the fold change in protein expression relative to control SCs is shown for HIF-1 alpha (D) HIF-2 alpha (E), VEGF (F), and enolase (G). Values are as follows: VP16 (control: 0.0 +/- 0.0; VP16: 0.40 +/- 0.01; VP16-HIF: 0.41 +/- 0.00); HIF-1 alpha (control: 1.0 +/- 0.04; VP16: 1.0 +/- 0.04; VP16-HIF: 5.9 +/- 0.01); HIF-2 alpha (control: 1.0 +/- 0.01; VP16: 1.0 +/- 0.01; VP16-HIF: 1.0 +/- 0.02); VEGF (control: 1.0 +/- 0.01; VP16: 1.02 +/- 0.02; VP16-HIF: 2.2 +/- 0.01); enolase (control: 1.0 +/- 0.01; VP16: 1.0 +/- 0.04; VP16-HIF: 1.7 +/- 0.00); n = 3/group. Mean +/- SEM, *p < 0.0001. Figure Contributions: Veena Kandaswamy generated the VP16-HIF cells. Veena Kandaswamy performed the PCRs. Ying Dai performed the western blottings. Ying Dai and Caitlin Hill analyzed the data. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/31488552), licensed under a CC-BY license. Not internally tested by Novus Biologicals.Applications for VEGF Antibody - BSA Free
Application
Recommended Usage
ELISA
1:500
Western Blot
1 ug/mL
Application Notes
In Western blot , a band is seen at ~42 kDa with a chimera transfected lysate representing the homodimer VEGFA. Another faint band is seen at ~21 kDa, representing the monomer form of VEGFA. The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. This antibody did not work in IHC.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
1.0 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: VEGF
References
1. Melincovici CS, Bosca AB, susman S, et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455-467.
2. Shaik F, Cuthbert GA, Homer-Vanniasinkam S, Muench SP, Ponnambalam S, Harrison MA. Structural Basis for Vascular Endothelial Growth Factor Receptor Activation and Implications for Disease Therapy. Biomolecules. 2020;10(12):1673. https://doi.org/10.3390/biom10121673
3. Apte RS, Chen DS, Ferrara N. VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019;176(6):1248-1264. https://doi.org/10.1016/j.cell.2019.01.021
4. Matsumoto K, Ema M. Roles of VEGF-A signalling in development, regeneration, and tumours. J Biochem. 2014;156(1):1-10. https://doi.org/10.1093/jb/mvu031
5. Itatani Y, Kawada K, Yamamoto T, Sakai Y. Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway. Int J Mol Sci. 2018;19(4):1232. Published 2018 Apr 18. doi:10.3390/ijms19041232
6. Uniprot (P15692)
7. Hamilton JL, Nagao M, Levine BR, Chen D, Olsen BR, Im HJ. Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain. J Bone Miner Res. 2016;31(5):911-924. https://doi.org/10.1002/jbmr.2828
Long Name
Vascular Endothelial Growth Factor
Alternate Names
MVCD1, VAS, Vasculotropin, VEGF-A, VEGFA, VPF
Gene Symbol
VEGFA
Additional VEGF Products
Product Documents for VEGF Antibody - BSA Free
Product Specific Notices for VEGF Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...